Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.
(2007) In Proceedings of the National Academy of Sciences 104(35). p.13966-13971- Abstract
- Research on the biology of the tumor stroma has the potential to lead to development of more effective treatment regimes enhancing the efficacy of drug-based treatment of solid malignancies. Tumor stroma is characterized by distorted blood vessels and activated connective tissue cells producing a collagen-rich matrix, which is accompanied by elevated interstitial fluid pressure (IFP), indicating a transport barrier between tumor tissue and blood. Here, we show that the collagen-binding proteoglycan fibromodulin controls stroma structure and fluid balance in experimental carcinoma. Gene ablation or inhibition of expression by anti-inflammatory agents showed that fibromodulin promoted the formation of a dense stroma and an elevated IFP.... (More)
- Research on the biology of the tumor stroma has the potential to lead to development of more effective treatment regimes enhancing the efficacy of drug-based treatment of solid malignancies. Tumor stroma is characterized by distorted blood vessels and activated connective tissue cells producing a collagen-rich matrix, which is accompanied by elevated interstitial fluid pressure (IFP), indicating a transport barrier between tumor tissue and blood. Here, we show that the collagen-binding proteoglycan fibromodulin controls stroma structure and fluid balance in experimental carcinoma. Gene ablation or inhibition of expression by anti-inflammatory agents showed that fibromodulin promoted the formation of a dense stroma and an elevated IFP. Fibromodulin-deficiency did not affect vasculature but increased the extracellular fluid volume and lowered IFP. Our data suggest that fibromodulin controls stroma matrix structure that in turn modulates fluid convection inside and out of the stroma. This finding is particularly important in relation to the demonstration that targeted modulations of the fluid balance in carcinoma can increase the response to cancer therapeutic agents. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/606673
- author
- Oldberg, Åke LU ; Kalamajski, Sebastian LU ; Salnikov, Alexei LU ; Stuhr, Linda ; Mörgelin, Matthias LU ; Reed, Rolf ; Heldin, Nils-Erik and Rubin, Kristofer LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- fluid pressure, interstitial, inflammation, tumor physiology, physiology, TGF-beta
- in
- Proceedings of the National Academy of Sciences
- volume
- 104
- issue
- 35
- pages
- 13966 - 13971
- publisher
- National Academy of Sciences
- external identifiers
-
- wos:000249187500022
- scopus:35348839617
- ISSN
- 1091-6490
- DOI
- 10.1073/pnas.0702014104
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Division III (013230700), Division V (013230900), Department of Experimental Medical Science (013210000), Åke Oldberg´s group (013212049), Oncology, MV (013035000), Connective Tissue Biology (013230151), Division of Infection Medicine (BMC) (013024020)
- id
- f8dd6d86-c095-4d50-8ed0-442972bba63e (old id 606673)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17715296&dopt=Abstract
- date added to LUP
- 2016-04-01 12:37:13
- date last changed
- 2022-03-29 03:19:31
@article{f8dd6d86-c095-4d50-8ed0-442972bba63e,
abstract = {{Research on the biology of the tumor stroma has the potential to lead to development of more effective treatment regimes enhancing the efficacy of drug-based treatment of solid malignancies. Tumor stroma is characterized by distorted blood vessels and activated connective tissue cells producing a collagen-rich matrix, which is accompanied by elevated interstitial fluid pressure (IFP), indicating a transport barrier between tumor tissue and blood. Here, we show that the collagen-binding proteoglycan fibromodulin controls stroma structure and fluid balance in experimental carcinoma. Gene ablation or inhibition of expression by anti-inflammatory agents showed that fibromodulin promoted the formation of a dense stroma and an elevated IFP. Fibromodulin-deficiency did not affect vasculature but increased the extracellular fluid volume and lowered IFP. Our data suggest that fibromodulin controls stroma matrix structure that in turn modulates fluid convection inside and out of the stroma. This finding is particularly important in relation to the demonstration that targeted modulations of the fluid balance in carcinoma can increase the response to cancer therapeutic agents.}},
author = {{Oldberg, Åke and Kalamajski, Sebastian and Salnikov, Alexei and Stuhr, Linda and Mörgelin, Matthias and Reed, Rolf and Heldin, Nils-Erik and Rubin, Kristofer}},
issn = {{1091-6490}},
keywords = {{fluid pressure; interstitial; inflammation; tumor physiology; physiology; TGF-beta}},
language = {{eng}},
number = {{35}},
pages = {{13966--13971}},
publisher = {{National Academy of Sciences}},
series = {{Proceedings of the National Academy of Sciences}},
title = {{Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.}},
url = {{https://lup.lub.lu.se/search/files/2997352/626099.pdf}},
doi = {{10.1073/pnas.0702014104}},
volume = {{104}},
year = {{2007}},
}